Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 05-oct-2026 · last seen 05-oct-2026

Chronic Subdural Hematoma as a Geroscience Disease

Current understanding

Chronic subdural hematoma (CSDH) — the commonest neurosurgical condition of older adults — is reframed in a 2026 minireview as a geroscience disease whose dural neomembrane biology and recurrence risk map onto the twelve hallmarks of aging, with chronic inflammation and altered intercellular communication nominated as the strongest contributors and senolytics/other gerotherapeutics proposed as mechanism-directed candidates [expert-opinion]. No gerotherapeutic has been tested against CSDH endpoints; the proposal is a research agenda, not a treatment claim, and the standard caveat about mechanism-to-human translation failures applies.

Evidence log

Open questions

Related

Contributing findings

pubmed review
Chronic subdural hematoma through the hallmarks of aging: a geroscience framework for the commonest neurosurgical condition of older adults.
10-aug-2026 novelty 3 per-area 3 introduces
pubmed review expert-opinion
Chronic subdural hematoma as failed resolution at the aged dura-subdural interface: Immune-vascular mechanisms, biomarker interpretation, and therapeutic translation.
11-jul-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18